興發集團(600141.SH):擬投資新建後坪磷礦200萬噸/年採礦工程項目
格隆匯12月30日丨興發集團(600141.SH)公佈,公司於2019年12月29日召開九屆十八次董事會審議通過了《關於公司投資新建後坪磷礦200萬噸/年採礦工程項目的議案》,投資概算75643萬元。
該項目建成投產後,公司將新增200萬噸/年磷礦產能,一方面有利於進一步發揮礦山經濟效益,同時優化公司肥料、黃磷等下游磷化工產品用礦來源,降低綜合成本,提升礦山對公司利潤的支撐作用;另一方面有利於增強公司磷礦資源保障能力,夯實公司磷化工上下游一體化產業鏈發展基礎,提升公司磷化工產業的綜合競爭優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.